Active — Not RecruitingNot Applicable

Treatment of Overactive Bladder With Anticholinergic Agents

Turkey (Türkiye)120 participantsStarted 2022-09-01

Plain-language summary

This study aims to evaluate the efficacy and adverse effect incidence of three different anticholinergics (oxybutinin, propiverine, and tolterodine) that are used in children with overactive bladder.

Who can participate

Age range5 Years – 17 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients diagnosed with overactive bladder * Patients treated with an anticholinergic Exclusion Criteria: * Presence of anatomical or neurological problems * Patients with missing data

What they're measuring

Number of patients treated with anticholinergic

Timeframe: 6 months

Number of patients with drug related adverse effects

Timeframe: 1 month

Trial details

NCT IDNCT07046156

SponsorSehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-06-30

View on ClinicalTrials.gov More Overactive Bladder trials